(OTC Bulletin Board: GNLK), a leading consumer genomics biotech company, is pleased to report that the Superior Court of
has affirmed the dismissal of the complaint filed by the Company's former CEO and President,
, and his wife (collectively, the "DePhillipos") against the Company, its subsidiary GeneWize Life Sciences, Inc., and several of the Company's officers, directors and advisors (collectively, the "GeneLink Parties"). The DePhillipos' appeal arose from the
May 5, 2009
Order and Opinion of the Court of Common Pleas of
wherein that Court dismissed the DePhillipos' claims as unviable.
About GeneLink BioSciences, Inc.:
GeneLink BioSciences is a genomics, biotechnology, and wellness company engaged in genetic profile development, product development, business development and support services for its subsidiaries and distribution partners. GeneLink's patented and patent pending technologies include proprietary genetic assessments and products linked to personalized health, beauty and wellness applications. For additional information, please visit
This release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in the press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GeneLink disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future developments or otherwise.
SOURCE GeneLink BioSciences, Inc.